MSPR_OUT_1 [2025-04-17 14:25:56 -0400] 4939 Bytes | 1241 tokens | Cum: 1241 tkns (15.51% of 8k)
==========================================================================

Alright, let’s light it up, because it's 2:25:55 PM on Thu Apr 17, 2025 -0400, and I'm charging into MSP Recovery (MSPR), popping from 1.7500 to 2.1700. Is this our star stock of the day, or just a quick blip on the radar? I've got the scoop—time to analyze!

--- COMPANY PROFILE ---
Company: MSP Recovery (MSPR)
IPO: IPO date unknown
Shares Outstanding: 2,110,000
Industry: SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Exchange: XNAS

Here’s a list of headlines for MSP Recovery:

Apr-16-25 06:06AM - MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results
Apr-10-25 07:26PM - MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth
Dec-06-24 12:52AM - LifeWallet Announces Consolidation of All Lines of Business Under the MSP Recovery Brand, While Advancing Initiatives That Align With the Newly Formed Department of Government Efficiency (DOGE)
Nov-21-24 11:43PM - LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple PandC Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE)
Nov-21-24 11:43PM 11:43PM - LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple P&C Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE)
Nov-14-24 04:24PM - LifeWallet Announces Third Quarter 2024 Financial Results
Nov-12-24 12:00PM - LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
Nov-11-24 10:21PM - LifeWallet Announces New Comprehensive Settlements Totaling More Than $5.9 Million, Continued Progress in Recoveries on Owned Claims and Acquiring Rights to Additional Claims, and Initiatives to Eliminate Wasteful Medicare Spending by Launching Beta Testing of Its Clearinghouse Solution, Built in Partnership with Palantir Technologies, Inc.

Prior AI Reports for MSPR:
1. 2025-04-02 – Score: 42 – Target: 1.6000 – Highs: 1.5800 / 1.4800 / 1.42
high-debt-and-negative-trends-cloud-companys-outlook

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-04-11T09:45:27Z - US Stocks Likely To Open Lower As Volatility Persists Before Bank Earnings: 'Fed Is Likely To Cut Rates Again On June 18th,' Says Expert
B2 - 2023-01-03T06:03:00Z - MSP Recovery, Inc. D/B/A LifeWallet, Begins Trading Today Under New NASDAQ Ticker Symbol LIFW
B3 - 2023-01-03T04:56:00Z - MSP Recovery, Now Doing Business as LifeWallet, Entered into a Term Sheet for the Monetization of a Portion of Its Company-owned Assignor Interests as a New Source of Monetization for $275 Million, and Payment of $48 Million in Servicing Fees for 2023
B4 - 2022-12-22T05:04:00Z - MSP Recovery Announces It Will Be Rebranding From MSP Recovery to Its Nationally Recognized Brand, “LifeWallet”
B5 - 2022-11-08T22:42:00Z - MSP Recovery Announces Fiscal Third Quarter 2022 Financial Results
B6 - 2022-10-28T01:43:00Z - MSP Recovery Expands Partnership with Tokenology Labs to Include Development of Multiple Blockchain Initiatives

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for MSP Recovery (MSPR).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

MSPR_OUT_3 [2025-04-17 14:25:57 -0400] 972 Bytes | 280 tokens | Cum: 1523 tkns (19.04% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**MSP Recovery, Inc. D/B/A LifeWallet, Begins Trading Today Under New NASDAQ Ticker Symbol LIFW**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2023/01/03/2581793/0/en/MSP-Recovery-Inc-D-B-A-LifeWallet-Begins-Trading-Today-Under-New-NASDAQ-Ticker-Symbol-LIFW.htmlCORAL GABLES, Fla., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. D/B/A LifeWallet (“LifeWallet”, or “the Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced the Company will commence trading of its common stock today, January 3, 2023 at 9:30 AM ET, under the new ticker symbol “LIFW”.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_5 [2025-04-17 14:25:58 -0400] 1006 Bytes | 277 tokens | Cum: 1802 tkns (22.53% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-16T17:06:28Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Biomerica (NASDAQ:BMRA), Acrivon Ther...
A2 - 2025-04-16T11:11:00Z - MSP Recovery, Inc. Reports Fiscal Year 2024 Financial Results and Strategic Developments...
A3 - 2025-04-16T10:18:06Z - MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results By Investing.com...
A4 - 2025-04-16T10:18:06Z - MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results By Investing.com...
A5 - 2025-04-16T10:18:06Z - MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results By Investing.com...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

MSPR_OUT_7 [2025-04-17 14:25:58 -0400] 1181 Bytes | 352 tokens | Cum: 2156 tkns (26.95% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Wednesday's Intraday Session - Biomerica (NASDAQ:BMRA), Acrivon Therapeutics (NASDAQ:ACRV)**Date: 2025-04-16Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44846392/12-health-care-stocks-moving-in-wednesdays-intraday-sessionGainers icad ICAD stock moved upwards by 73.0% to $3.34 during Wednesday's regular session. The market value of their outstanding shares is at $88.0 million. Universe Pharmaceuticals UPC stock increased by 26.25% to $4.18. The market value of their outstanding shares is at $63.6 million. Zhengye Biotechnology ZYBT stock increased by 22.87% to $7.09. The company's market cap stands at $336.0 million. Mira Pharmaceuticals MIRA shares rose 21.48% to $1.09. The company's market cap stands at $18.0 million. Jupiter Neurosciences JUNS shares rose 18.94% to $0.69

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_9 [2025-04-17 14:25:59 -0400] 1181 Bytes | 341 tokens | Cum: 2499 tkns (31.24% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): . The company's market cap stands at $22.8 million. Phio Pharma PHIO shares moved upwards by 18.11% to $2.87. The company's market cap stands at $13.7 million. Losers Syra Health SYRA stock declined by 34.4% to $0.13 during Wednesday's regular session. The market value of their outstanding shares is at $1.6 million. Biomerica BMRA stock fell 26.31% to $0.42. The market value of their outstanding shares is at $7.7 million. The company's, Q3 earnings came out 2 days ago. China SXT Pharmaceuticals SXTC stock decreased by 19.52% to $1.37. The company's market cap stands at $18.8 million. MSP Recovery MSPR shares declined by 19.05% to $1.87. The market value of their outstanding shares is at $3.9 million. As per the news, the Q4 earnings report came out today. Acrivon Therapeutics ACRV shares declined by 17.24% to $1.78. The company's market cap stands at $55.4 million. LogicMark LGMK shares

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_11 [2025-04-17 14:26:00 -0400] 1123 Bytes | 371 tokens | Cum: 2872 tkns (35.90% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): fell 15.84% to $0.01. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACRVAcrivon Therapeutics Inc$1.79-16.7%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum3.24Price TrendShortMediumLongOverviewBMRABiomerica Inc$0.4205-26.2%ICADicad Inc$3.3171.5%JUNSJupiter Neurosciences Inc$0.678417.0%LGMKLogicMark Inc$0.0100-16.3%MIRAMira Pharmaceuticals Inc$1.0719.3%MSPRMSP Recovery Inc$1.87-19.1%PHIOPhio Pharmaceuticals Corp$2.9019.3%SXTCChina SXT Pharmaceuticals Inc$1.39-18.2%SYRASyra Health Corp$0.1300-36.5%UPCUniverse Pharmaceuticals Inc$3.7413.0%ZYBTZhengye Biotechnology Holding Ltd$7.0121.5%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_13 [2025-04-17 14:26:01 -0400] 1036 Bytes | 298 tokens | Cum: 3172 tkns (39.65% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-15 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

The following discussion and analysis provides information that management believes is relevant ...

S2 - 2025-04-10 8-K Item 1.01. Entry into a Material Definitive Agrmt.

Reorganization Term Sheet

On April 4, 2025, Virage Recovery Master, LP (Virage); Virage Capital Management, LP; Hazel Partners Holdings, LLC (HPH); Hazel Holdings I, LLC (and together with HPH, Hazel); La Ley con John H. ...

S4 - 2001-05-14 10-Q PART I. FIN INFO

Item 1. Cons Fin Stmnts

MAINSPRING, INC. CONS BAL SHEET (in thousands, except share and per share data)

December 31, 2000

March 31, 2001

Assets (unaudited)

Curr assets: Cash and cash equiv $ 70,8...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

MSPR_OUT_15 [2025-04-17 14:26:01 -0400] 1181 Bytes | 240 tokens | Cum: 3414 tkns (42.68% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations.

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of the Companys consolidated results of operations and financial condition. This Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this Annual Report on Form 10-K (the Annual Report). Unless the context otherwise requires, all references in this subsection to we, or the Company refers to Legacy MSP prior to the Business Combination and the Company after the Business Combination. This discussion may contain forward-looking statemen

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_17 [2025-04-17 14:26:02 -0400] 1181 Bytes | 233 tokens | Cum: 3649 tkns (45.61% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): ts based upon the Companys current expectations, estimates, and projections that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements due to, among other considerations, the matters discussed under Risk Factors and Cautionary Note Regarding Forward-Looking Statements.

Our Business

MSP Recovery is a leading healthcare reimbursement recovery and data analytics company, providing historical and Near Real-Time solutions for payers, providers, and patients. We focus on discovering losses and recovering improper payments for Medicare, Medicaid, and commercial health insurers, disrupting the antiquated healthcare reimbursement system. We also provide innovative technology and comprehensive services for multiple industries including healthcare and legal.

Medicare and Medicaid are payers of last resort. Too often,

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_19 [2025-04-17 14:26:02 -0400] 1181 Bytes | 245 tokens | Cum: 3896 tkns (48.70% of 8k)
==========================================================================

Showing S1 (chunk 3 of 6): they end up being the first and only payers, because the responsible payer is not identified or billed. As Medicare and Medicaid pay a far lower rate than what other insurers are often billed, this costs the healthcare system (and the supporting taxpayers) tens of billions of dollars a year attributable to improper billing and lost recoveries. By discovering, quantifying, and settling the billed-to-paid gap on a large-scale basis, the Company is positioned to generate meaningful annual recovery revenue at high profit margins.

Our access to large volumes of data, sophisticated data analytics platforms, and advanced technology provide a unique opportunity to discover and recover improper healthcare Claims payments. We have developed Algorithms to identify waste, fraud, and abuse in the Medicare, Medicaid, and commercial health insurance sectors. Our team of experienced data scientists a

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_21 [2025-04-17 14:26:03 -0400] 1181 Bytes | 250 tokens | Cum: 4148 tkns (51.85% of 8k)
==========================================================================

Showing S1 (chunk 4 of 6): nd medical professionals analyze historical medical Claims data to identify recoverable opportunities. Once potential recoveries are reviewed by our team, they are aggregated and pursued. Through statutory law and case law, we believe we have an established basis for future recoveries.

We differ from our competitors as we receive our recovery rights through irrevocable assignments of Claims. When we are assigned these rights by our clients, we assume risk that our competitors do not. Rather than provide services under a third-party vendor services contract, we receive the rights to certain recovery proceeds from our Assignors Claims (and, in most cases, take assignment of the Claims themselves, allowing us to step into the Assignor clients shoes). As we, or our affiliated entities, are assigned the recovery rights associated with Claims, we are the plaintiff in any action filed and the

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_23 [2025-04-17 14:26:04 -0400] 1181 Bytes | 251 tokens | Cum: 4401 tkns (55.01% of 8k)
==========================================================================

Showing S1 (chunk 5 of 6): refore exercise control over the direction of the litigation. By receiving Claims through assignment, we can pursue additional recoveries under numerous legal theories that our competitors cannot. Although we own the assigned Claims, for a significant portion of assigned Claims, our ability to pursue recoveries depends on our ongoing access to data associated with those Claims through data access rights granted to us. The termination of said data access rights would substantially impair our ability to generate recoveries on those Claims.

We are entitled to a portion of any recovery rights associated with approximately $1,591 billion in Billed Amount (and approximately $380 billion in Paid Amount), which contains approximately $87.7 billion in Paid Value of Potentially Recoverable Claims, as of December 31, 2024. We believe it would take any competitor significant time to amass the port

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_25 [2025-04-17 14:26:06 -0400] 790 Bytes | 179 tokens | Cum: 4582 tkns (57.27% of 8k)
==========================================================================

Showing S1 (chunk 6 of 6): folio of Claims rights currently owned by us due to, among things, the volume of our Claims data retained and strength of our data analytics, which we believe are key to attracting new clients that are willing to assign Claims to us.

Healthcare Industry

Our business is directly related to the healthcare industry and is affected by healthcare spending and complexity in the healthcare industry. We estimate that our total potentially serviceable market is over $161.5 billion annually. Our primary f...

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MSPR_OUT_27 [2025-04-17 14:26:14 -0400] 5960 Bytes | 1580 tokens | Cum: 6164 tkns (77.05% of 8k)
==========================================================================

This is our set of metrics for MSP Recovery.
Please analyze the numbers.

+-------------------+------------------------+------------------------+------------------------+
| Volume: 147,339 | Perf Month: 48.23% | Option/Short: No / Yes | Sales Y/Y TTM: 136.85% |
+-------------------+------------------------+------------------------+------------------------+
| Avg Volume: 1.74M | Perf Quarter: -10.30% | Short Float: 7.50% | ROE: -193.31% |
+-------------------+------------------------+------------------------+------------------------+
| Rel Volume: 0.12 | Index: - | Short Ratio: 0.06 | ROI: -41.72% |
+-------------------+------------------------+------------------------+------------------------+
| RSI (14): 54.78 | Market Cap: 14.79M | Short Interest: 0.10M | Sales Surprise: - |
+-------------------+------------------------+------------------------+------------------------+
| ATR (14): 0.43 | Shs Outstand: 2.18M | Beta: -2.46 | EPS Surprise: - |
+-------------------+------------------------+------------------------+------------------------+
| SMA20: 30.44% | Shs Float: 1.30M | Sales Q/Q: 1032.28% | P/E: - |
+-------------------+------------------------+------------------------+------------------------+
| SMA50: 6.99% | Inst Own: 18.92% | Sales past 5Y: - | Earnings: - |
+-------------------+------------------------+------------------------+------------------------+
| SMA200: -45.60% | Insider Own: 38.27% | Employees: 78 | |
+-------------------+------------------------+------------------------+------------------------+
| Perf Week: 63.28% | Insider Trans: -39.02% | Debt/Eq: 19.10 | |
+-------------------+------------------------+------------------------+------------------------+

The next section covers any insider trading by MSP Recovery officers or majority shareholders (if available).

No transactions recorded.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 10734000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -804785000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 2.17
Average Volume: 4005020.43
30-Day High: 2.83
30-Day Low: 1.22

[Detailed Financials: FY 2022]
- Total Assets: $3,417,945,000.00
- Total Liabilities: $1,230,673,000.00
- Total Equity: $2,185,465,000.00
- Current Assets: $51,357,000.00
- Current Liabilities: $115,715,000.00

[Income Statement: FY 2022]
- Revenue: $23,420,000.00
- Net Income: $-401,905,000.00
- Gross Profit: N/A
- Operating Income: $-331,478,000.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: FY 2022]
- Net Cash Flow: $13,416,000.00

[Detailed Financials: Q3 2022]
- Total Assets: $3,543,791,000.00
- Total Liabilities: $1,181,066,000.00
- Total Equity: $2,361,369,000.00
- Current Assets: $67,785,000.00
- Current Liabilities: $882,992,000.00

[Income Statement: Q3 2022]
- Revenue: $8,507,000.00
- Net Income: $-105,556,000.00
- Gross Profit: N/A
- Operating Income: $-125,184,000.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q3 2022]
- Net Cash Flow: $-10,777,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of MSP Recovery (MSPR).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about MSP Recovery.

2) MARKET_SCORE[]
This conversation was initiated because MSPR is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for MSPR.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, MSPR could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect MSPR to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of MSP Recovery.

11) ETHICAL_RATING[]
Rate MSP Recovery’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of MSP Recovery.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

MSPR_IN_29 [2025-04-17 14:26:15 -0400] 126 Bytes | 29 tokens | Cum: 6372 tkns (79.65% of 8k)
==========================================================================

====================================
[2025-04-17 14:26:15] # Analysis Completed
Elapsed Time: 19.88 seconds